Category

News Brief

Will Genome Modifications Define Next-Gen AAV Vectors?

UF researcher Arun Srivastava, Ph.D., a gene therapy pioneer, shares his expert perspective on genome-modified AAV vectors, offering insights into how next-generation viral therapies may be shaped by precision genetic engineering.
1 2 3 262